Literature DB >> 12011416

Progress in rapid screening of Bacillus anthracis lethal factor activity.

Michèle Mock1, Bernard P Roques.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12011416      PMCID: PMC124435          DOI: 10.1073/pnas.112220599

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  21 in total

1.  Crystal structure of the anthrax lethal factor.

Authors:  A D Pannifer; T Y Wong; R Schwarzenbacher; M Renatus; C Petosa; J Bienkowska; D B Lacy; R J Collier; S Park; S H Leppla; P Hanna; R C Liddington
Journal:  Nature       Date:  2001-11-08       Impact factor: 49.962

2.  A peptide-based fluorescence resonance energy transfer assay for Bacillus anthracis lethal factor protease.

Authors:  Richard T Cummings; Scott P Salowe; Barry R Cunningham; Judyann Wiltsie; Young Whan Park; Lisa M Sonatore; Douglas Wisniewski; Cameron M Douglas; Jeffrey D Hermes; Edward M Scolnick
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-07       Impact factor: 11.205

Review 3.  Recent developments in the design of angiotensin-converting enzyme inhibitors.

Authors:  M J Wyvratt; A A Patchett
Journal:  Med Res Rev       Date:  1985 Oct-Dec       Impact factor: 12.944

4.  Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor.

Authors:  N S Duesbery; C P Webb; S H Leppla; V M Gordon; K R Klimpel; T D Copeland; N G Ahn; M K Oskarsson; K Fukasawa; K D Paull; G F Vande Woude
Journal:  Science       Date:  1998-05-01       Impact factor: 47.728

5.  A unique signature identifies a family of zinc-dependent metallopeptidases.

Authors:  C V Jongeneel; J Bouvier; A Bairoch
Journal:  FEBS Lett       Date:  1989-01-02       Impact factor: 4.124

Review 6.  Neutral endopeptidase 24.11: structure, inhibition, and experimental and clinical pharmacology.

Authors:  B P Roques; F Noble; V Daugé; M C Fournié-Zaluski; A Beaumont
Journal:  Pharmacol Rev       Date:  1993-03       Impact factor: 25.468

7.  Proteasome activity is required for anthrax lethal toxin to kill macrophages.

Authors:  G Tang; S H Leppla
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

8.  Collaborative study of a method for the detection of Clostridium botulinum and its toxins in foods.

Authors:  D A Kautter; H M Solomon
Journal:  J Assoc Off Anal Chem       Date:  1977-05

9.  Metallopeptidase inhibitors of tetanus toxin: A combinatorial approach.

Authors:  L Martin; F Cornille; S Turcaud; H Meudal; B P Roques; M C Fournié-Zaluski
Journal:  J Med Chem       Date:  1999-02-11       Impact factor: 7.446

10.  Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin.

Authors:  G Schiavo; F Benfenati; B Poulain; O Rossetto; P Polverino de Laureto; B R DasGupta; C Montecucco
Journal:  Nature       Date:  1992-10-29       Impact factor: 49.962

View more
  5 in total

1.  Using temporal context to improve biosurveillance.

Authors:  Ben Y Reis; Marcello Pagano; Kenneth D Mandl
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-06       Impact factor: 11.205

2.  Cloning and expression of an inhibitor of microbial metalloproteinases from insects contributing to innate immunity.

Authors:  Anja Clermont; Marianne Wedde; Volkhard Seitz; Lars Podsiadlowski; Dido Lenze; Michael Hummel; Andreas Vilcinskas
Journal:  Biochem J       Date:  2004-08-15       Impact factor: 3.857

Review 3.  Binary bacterial toxins: biochemistry, biology, and applications of common Clostridium and Bacillus proteins.

Authors:  Holger Barth; Klaus Aktories; Michel R Popoff; Bradley G Stiles
Journal:  Microbiol Mol Biol Rev       Date:  2004-09       Impact factor: 11.056

Review 4.  Anthrax lethal toxin and the induction of CD4 T cell immunity.

Authors:  Stephanie Ascough; Rebecca J Ingram; Daniel M Altmann
Journal:  Toxins (Basel)       Date:  2012-10-19       Impact factor: 4.546

5.  Anthrax lethal factor as an immune target in humans and transgenic mice and the impact of HLA polymorphism on CD4+ T cell immunity.

Authors:  Stephanie Ascough; Rebecca J Ingram; Karen K Chu; Catherine J Reynolds; Julie A Musson; Mehmet Doganay; Gökhan Metan; Yusuf Ozkul; Les Baillie; Shiranee Sriskandan; Stephen J Moore; Theresa B Gallagher; Hugh Dyson; E Diane Williamson; John H Robinson; Bernard Maillere; Rosemary J Boyton; Daniel M Altmann
Journal:  PLoS Pathog       Date:  2014-05-01       Impact factor: 6.823

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.